GlobalSign
A strategic digital signing partnership to secure your signature
LEUVEN, BE / ACCESSWIRE / May 24, 2023 / GMO GlobalSign Ltd. (https://www.globalsign.com), a global Certificate Authority (CA) and leading provider of digital signing, identity and security solutions for the IoT, has announced today its successful establishment of a technology partnership with eXsolut GmbH.
eXsolut has been successfully providing digital signing delivered by GlobalSign's Digital Signing Service (DSS). In that time, hundreds of eXsolut customers have used GlobalSign's DSS product to send digitally signed emails and timestamps to customers throughout Europe. eXsolut sells a smart document management system called TeamDocument a central, on-premises solution optimizing information security and access. Together with GlobalSign, TeamDocument offers the highest security thanks to visibility of the workflow the solution itself provides. Also, editing is restricted to user access within any organization that uses Document Management System (DMS) with a hierarchy of people on different levels,.
eXsolut's CEO Sayit Özdemir explained: "GlobalSign is our new partner for the secure handling of information and documents - the essentials of every modern company.
Together, GlobalSign and eXsolut stand for sustainable and accessible knowledge in times of digital transformation. We are delighted about this partnership!"
DSS is ideally matched with eXsolut's Enterprise Communication and Enterprise Task & Document Management for GlobalSign to manage and sign documents in a safe and digital manner. The main driver for this partnership was that eXsolut required digitally trusted signatures, helping to secure documents to improve traceability and auditability. Bundling eXsolut and GlobalSign together made perfect sense for customers of both organizations across different sectors as it saves time, cost and resources. Many customers chose a digital signature as a complement to DMS due to the increasing need to adhere to compliance and secure communication. Today, digital identity is very important within the manufacturing industry but the pathways to a solution can be complex. Providers offering digital signing within their platform or solution as a feature is the way to digitalize workflows and processes for their customer. To have a clear workflow and approval process is critical. Building a digital identity as an additional layer of credibility adds increased methods to audit.
Account Manager Jerker Svensson emphasizes: "GlobalSign is looking forward to a dynamic and mutually productive partnership with eXsolut, in realizing sophisticated customer projects in the area of document management combined with digital signatures. We are excited about creating customer success together in the future."
About eXsolut
eXsolut has over 20 years' experience as a German software developer. Their focus is on communication, collaboration and knowhow management solutions for organizations in their digital transformation to improve interpersonal workflows and create a sustainable documentation and foundation for collaboration. The idea of quality management is established at the core of the solutions, which is why the solutions receive best practice awards in audits at renowned industrial companies. International customers from different industries and use cases shape the solutions, which are continuously developed and aligned to the processes, needs and wishes of the customers.
About GMO GlobalSign
As one of the world's most deeply-rooted certificate authorities, GMO GlobalSign is the leading provider of trusted identity and security solutions enabling businesses, large enterprises, cloud-based service providers, and IoT innovators worldwide to conduct secure online communications, manage millions of verified digital identities and automate authentication and encryption. Its high-scale Public Key Infrastructure (PKI) and identity solutions support the billions of services, devices, people, and things comprising the IoT. GMO GlobalSign is a subsidiary of GMO GlobalSign Holdings, Inc, a member of the Japan-based GMO Internet Group, has offices in the Americas, Europe and Asia. For more information, visit https://www.globalsign.com.
Media contact
Melanie Faller
France/DACH PR-Manager - EMEA
Phone: + 44 73 111 99 821
E-Mail: Melanie.Faller@globalsign.com
SOURCE: GlobalSign
View source version on accesswire.com:
https://www.accesswire.com/756774/GlobalSign-Partners-with-eXsolut-Throughout-Europe
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Karbon-X Celebrates Major Milestone in Senegal Mangrove Restoration Project28.10.2025 13:00:00 CET | Press release
Planting completed across 7,000 hectares in partnership with Woodside Energy, advancing community-led climate action. DAKAR, SN / ACCESS Newswire / October 28, 2025 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company") is proud to announce a significant milestone in its ABC Mangrove Project, one of West Africa's largest community-led restoration initiatives with the successful completion of planting across more than 7,000 hectares of mangroves along Senegal's coastline. Developed through ALLCOT, Karbon-X's project development and advisory arm (ALLCOT-A Karbon-X Company), and in partnership with Woodside Energy, the project is helping restore critical blue-carbon ecosystems that protect biodiversity, strengthen local economies, and capture carbon naturally from the atmosphere. Through this multi-year effort, thousands of local community members have been engaged in the planting and care of mangroves, creating new jobs, skills training, and sustainable income opportunities for wome
Florence Healthcare Launches SiteLink on AWS Marketplace, Extending its Clinical Trial Operations Platform Capabilities to Cloud28.10.2025 13:00:00 CET | Press release
ATLANTA, GEORGIA / ACCESS Newswire / October 28, 2025 / Florence Healthcare, the leading clinical trial platform connecting pharmaceutical sponsors and research sites worldwide, announced today that SiteLink, a key offering of Florence's Trial Operations Platform, is now available in AWS Marketplace. SiteLink accelerates study startup and enables real-time document distribution, monitoring, and data exchange with study sites, addressing the critical digital divide in clinical trials. With only 30% of global research sites currently using digital workflows, SiteLink helps bridge this gap by automating sponsor-site operational workflows. Bringing the Florence Trial Operations Platform Benefits to AWS As a core component of Florence's Trial Operations Platform, SiteLink delivers the same proven results that have made Florence the #1 clinical trial management solution for six consecutive years. The platform enables: Faster Startup: Up to 70% faster study activation timelines through automa
GoodData Brings AI-Native Data Intelligence to Financial Services28.10.2025 10:00:00 CET | Press release
Embeddable, compliant, and auditable AI agents unlock trusted automation for banks, insurers, and financial institutions. SAN FRANCISCO, CA / ACCESS Newswire / October 28, 2025 / GoodData, a leading analytics and data intelligence company, today unveiled new finance-focused applications for its composable AI platform, designed to tackle the industry's toughest challenges. By combining its AI Lake, AI Hub, and AI Apps into a single foundation for enterprise data intelligence, the next-generation platform gives financial institutions powerful tools to build and deploy AI agents. These agents can detect and investigate fraud in seconds with audit trails regulators can trust, keeping portfolios compliant in real time within industry guidelines. This streamlines regulatory reporting by compiling, checking, and submitting disclosures transparently, all while meeting strict standards for financial compliance, governance, and security. Purpose-built for finance The financial services sector fa
Cambridge Isotope Laboratories, Inc. Unveils ISOAPI-D - a New Standard in Deuterated Reagents for Pharmaceutical Innovation - at CPhI Frankfurt 202527.10.2025 14:00:00 CET | Press release
With ISOAPI-D, CIL offers pharmaceutical partners a secure, global supply of deuterated reagents - manufactured to the highest quality standards for faster, more efficient API development. TEWKSBURY, MASSACHUSETTS / ACCESS Newswire / October 27, 2025 / Cambridge Isotope Laboratories, Inc. (CIL), a global leader in stable isotope chemistry, announces the launch of ISOAPI-D™, a unified brand of deuterated intermediates for API synthesis. The new ISOAPI-D brand will be launched at CPhI Frankfurt, where CIL welcomes industry professionals to stand #2.0G2 from October 28-30.ISOAPI-D ISOAPI-D Power of Deuterium: Smarter, Stronger Therapeutics "ISOAPI-D reagents are designed to support the development of next-generation active pharmaceutical ingredients (APIs) by leveraging the unique benefits of deuterium incorporation," said Cliff Caldwell, CEO of CIL. "With ISOAPI-D, our customers gain access to a trusted and secure supply chain, ensuring they have consistent, reliable access to the materi
Cambridge Isotope Laboratories, Inc. and Chemtatva Chiral Solutions Pvt. Ltd. to Establish Cambridge Isotope Laboratories, Pvt. Ltd. in Hyderabad, India27.10.2025 13:45:00 CET | Press release
Strategic Partnership to Establish Cambridge Isotope Laboratories, Pvt. Ltd. in Hyderabad's Genome Valley, Enhancing Global Production and Supply of Isotopically Enriched Chemical Solutions for Pharmaceutical and Electronics Industries TEWKSBURY, MA AND HYDERABAD, INDIA / ACCESS Newswire / October 27, 2025 / Cambridge Isotope Laboratories, Inc. (CIL), and Chemtatva Chiral Solutions, Pvt. Ltd. (CCS), a leading provider of chiral and specialty chemical solutions, announce the execution of a signed Memorandum of Understanding to establish Cambridge Isotope Laboratories, Pvt. Ltd. in Hyderabad, India. This initiative marks a milestone in the expansion of CIL's global footprint and further enhances capabilities in the development and production of deuterated reagents and other isotopically enriched products. This partnership will enhance global supply chain strength and real-time support for customers in Asia and enable multi-site production for global customers focused on business continui
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
